• Popular Recommendations

  • PEER
  • ultrasound
  • LLSA
  • sepsis

Emergency Department Sickle Cell Care Coalition

COLLABORATION

EDSC3 hosted the Summit on Improving Emergency Department Care for Sickle Cell Disease in August 2018, bringing together patient advocacy groups, medical socities and governmental agencies to discuss ways to improve care.  Participants identified concrete and specific actions to improve care in the ED within their own organizations, discussed current and future initiatives and learned about areas they could collaborate effecitively.  A follow up summit will be held in May of 2019.  

 

QUALITY IMPROVEMENT 

Sickle cell disease (SCD) is a multisystem, progressive disorder that affects approximately 100,000 Americans, primarily of African and Hispanic descent. While considered a rare disease by the National Institutes of Health, SCD is one of the most common genetic blood disorders in the US.  Patients with SCD often require care in emergency departments (EDs), most commonly seek treatment for pain due to vaso-occlusive episodes.  Improving the care of patients with SCD requires a systems approach, focused on both the care provided in the ED as well as post-acute care visits care coordination and follow-up. 

In recognition of the need to improve the care of patients with SCD, ACEP along with Pfizer, offered a grant opportunity focused on supporting quality improvement initiatives designed to improve the assessment and treatment of acute vaso-occlusive crisis pain for adult patients with sickle cell disease treated in Emergency Departments (EDs) in the United States. Six centers in the United States were awarded these grants (see below). 

Improving Assessment and Treatment of Acute Vaso-occlusive Crisis Pain in the ED Setting Grantees:

Project Title

Principal Investigator

Project Location

CRISIS-Collaborative Response In SIckle Cell Systematization

Corrie Chumpitazi, MD MS

Baylor College of Medicine in Houston, Texas

System Level Informatics Interventions to Improve ED Care of VOC

Jeffrey Glassberg, MD MA

Icahn School of Medicine at Mount Sinai in New York, New York

Sickle Cell Vaso-occlusive Crisis

Anuj Vohra, DO

Orange Regional Medical Center in Middleton, New York

Sickle Cell Disease Patient Navigation Program

R. Gentry Wilkerson, MD

University of Maryland Baltimore in Baltimore, Maryland

Subcutaneous Opioids at Triage to Treat Acute Vaso-Occlusive Crises

Caroline Freiermuth, MD

University of Cincinnati Health in Cincinnati, Ohio

Improving Assessment & Treatment of Vaso-occlusive crisis in the ED

Shreni Zinzuwadia, MD

Beth Israel in Newark, New Jersey

 

 

LIVE CHAT
[ Feedback → ]